News

21.12.2022

EMSP joins new EU funded project called More-EUROPA

While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real-world data (RWD)…

HTx – Next Generation Health Technology Assessment

26.10.2021

How to decide on the best standard of care for a person with MS? What if patients could contribute to…